Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication:: Clinical and laboratory effects

被引:72
作者
Geusau, A
Abraham, K
Geissler, K
Sator, MO
Stingl, G
Tschachler, E
机构
[1] Univ Vienna, Sch Med, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria
[2] Humboldt Univ, Charite Childrens Hosp, Dept Pediat Pneumol & Immunol, Berlin, Germany
[3] Univ Vienna, Sch Med, Dept Med, Div Hematol, A-1090 Vienna, Austria
[4] Univ Vienna, Sch Med, Dept Obstet & Gynecol, Div Gynecol Endocrinol & Reprod Med, A-1090 Vienna, Austria
关键词
amenorrhoea; anemia; chloracne; dioxin intoxication; endocrine effects; health effects; TCDD;
D O I
10.2307/3454832
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
A variety of health effects have been attributed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), but little information is available on the course of a verified high-level TCDD intoxication. In this paper we describe two cases of heavy intoxication with TCDD and present a 2-year follow-up including clinical, biochemical, hematologic, endocrine, and immunologic parameters monitored in two women, 30 and 27 years of age, who suffered from chloracne due to TCDD intoxication of unknown origin. Patient 1, who had the highest TCDD level ever recorded in an individual (144,000 pg/g blood fat), developed severe generalized chloracne, whereas in the second patient, despite heavy intoxication (26,000 pg/g, blood fat), only mild facial acne lesions occurred. Both patients initially experienced nonspecific gastrointestinal symptoms. In Patient 1 we observed a moderate elevation of blood lipids, leukocytosis, anemia, and secondary amenorrhoea. The laboratory parameters in Patient 2 were all normal. Despite the high TCDD levels, apart from chloracne, only few clinical and biochemical health effects were observed within the first 2 years after TCDD intoxication.
引用
收藏
页码:865 / 869
页数:5
相关论文
共 28 条
[1]   The Seveso studies on early and long-term effects of dioxin exposure: A review [J].
Bertazzi, PA ;
Bernucci, I ;
Brambilla, G ;
Consonni, D ;
Pesatori, AC .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 :625-633
[2]  
Coenraads PJ, 1999, BRIT J DERMATOL, V141, P694
[3]   Gonadotropin-releasing hormone (GnRH) partially reverses the inhibitory effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on ovulation in the immature gonadotropin-treated rat [J].
Gao, X ;
Petroff, BK ;
Rozman, KK ;
Terranova, PF .
TOXICOLOGY, 2000, 147 (01) :15-22
[4]   Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin [J].
Geusau, A ;
Tschachler, E ;
Meixner, M ;
Sandermann, S ;
Päpke, O ;
Wolf, C ;
Valic, E ;
Stingl, G ;
McLachlan, M .
LANCET, 1999, 354 (9186) :1266-1267
[5]   Punctate keratoderma-like lesions on the palms and soles in a patient with chloracne: a new clinical manifestation of dioxin intoxication? [J].
Geusau, A ;
Jurecka, W ;
Nahavandi, H ;
Schmidt, JB ;
Stingl, G ;
Tschachler, E .
BRITISH JOURNAL OF DERMATOLOGY, 2000, 143 (05) :1067-1071
[6]  
GRIFFIN JE, 1992, WILLIAMS TXB ENDOCRI, P1663
[7]   A REVIEW OF 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN-INDUCED CHANGES IN IMMUNOCOMPETENCE - 1991 UPDATE [J].
HOLSAPPLE, MP ;
SNYDER, NK ;
WOOD, SC ;
MORRIS, DL .
TOXICOLOGY, 1991, 69 (03) :219-255
[8]  
Kaiser J, 2000, SCIENCE, V288, P1941
[9]  
KONIG MP, 1988, SCHWEIZ MED WOCHENSC, V116, P265
[10]   A risk-benefit assessment of sulpiride in the treatment of schizophrenia [J].
Mauri, MC ;
Bravin, S ;
Bitetto, A ;
Rudelli, R ;
Invernizzi, G .
DRUG SAFETY, 1996, 14 (05) :288-298